Nature Communications (journal) Archive — Page 1 of 5

May 12, 2026

Human islet function, diabetes risk defined by heterogeneous endocrine cell composition

Multisite consortium analyzed human pancreatic islet cells from nondiabetic organ donors in innovative method to better understand pathophysiology of diabetes.

April 8, 2026

Adding steps offsets risk of chronic disease: Study

Using Fitbits, researchers set out to discover how many additional steps patients need to reduce risks of chronic disease.

February 6, 2026

New analytical approach identifies novel risk genes for colorectal cancer

The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

Stokes Peebles, MD, right, Mark Rusznak, PhD, and their colleagues have identified a potential drug target for treating asthma. (photo by Erin O. Smith)
February 4, 2026

Broad genetic study reveals new drug target for asthma

The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

(iStock image)
December 8, 2025

Interim data reported for multiple myeloma off-the-shelf CAR-T therapy  

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.

(iStock)
September 30, 2025

Studies find connection between impaired musical rhythm abilities and developmental speech-language disorders 

Evidence showed that deficiency in musical rhythm perception is a “modest but consistent risk factor for developmental speech, language and reading disorders.”